Hi-
I was wondering if anyone had information regarding specific amounts of excipients or preservatives that is considered harmful in the neonatal population? Thanks so much!
~Kara

Kara M. Bozik, PharmD, BCPS
UNC Rex Healthcare
Raleigh, NC

Hi-
I was wondering if anyone had information regarding specific amounts of excipients or preservatives that is considered harmful in the neonatal population? Thanks so much!
~Kara

Kara M. Bozik, PharmD, BCPS
UNC Rex Healthcare
Raleigh, NC

I wanted to find out how others are dispensing liquid medications for g-tube administration? Are you dispensing in an "oral syringe"? Are you color coding the syringe tip? IF you're a peds institution, is it ordered and/or dispensed differently when the provider wants it added to feeds? Do you have special labeling?

Thanks in advance.
DiAnthia

What is the process in your institution for use of half or quarter patches? How are they applied? Do you cover half the undersurface of the patch or fold up the active portion?

Or do you not allow 1/2 or 1/4 patches?

Thanks,

Randi

I would like to know if there are any institutions willing to share information on the use of Botox in their clinic setting. In particular, I am looking to see if USP 797 practices (for SDV) are in place OR if practice is to the package insert (vial good for up to 24 hours after reconstitution and under refrigeration)OR if other practices (reconstitution with Bacteriostatic Saline for BUD extension beyond PI guidelines)are in play. Or, if there is any other solution (e.g.: Pharmacy drawing up under USP 797 to batch out).

Thanks!

I would like to know if there are any institutions willing to share information on the use of Botox in their clinic setting. In particular, I am looking to see if USP 797 practices (for SDV) are in place OR if practice is to the package insert (vial good for up to 24 hours after reconstitution and under refrigeration)OR if other practices (reconstitution with Bacteriostatic Saline for BUD extension beyond PI guidelines)are in play. Or, if there is any other solution (e.g.: Pharmacy drawing up under USP 797 to batch out).

Thanks!

We are embarking on a study evaluating a tool that assesses the risk of a prescribing error associated with a particular medication - your help is needed for face validation efforts. I'm happy to share the tool (it's in an Excel sheet) and any acknowledgements according to contributions.

I posted an earlier thread regarding access to EHR Test environments for medication safety pharmacists. I'm happy to report that the information shared by others helped me to successfully solicit access for our safety leads! Thank you!

NOW I have a different question...

Hello all,

I am curious how other hospitals manage therapeutic duplications between anesthesiologists and surgeons. Currently, anesthesia orders analgesics and antiemetic agents for "PACU use only" but surgeons will often order similar medications before the anesthesia orders have been discontinued. Our hospital uses Cerner for CPOE and I was wondering how others hospitals handle this issue.

Thank you,

Jim

Good morning,

We are in the process of developing USP 800 Hazardous Med Education for nursing. Has anyone developed the nursing component of education and are you willing to share? Specifically looking for how nursing will identify the hazardous med, PPE requirements and how you plan to hardwire the process.

Thank you,

Kelly Biastre, PharmD
Sr. Consultant Med Safety
Baptist Health
Jacksonville, Fl